Cita APA

Martinez-Useros, J., Rodriguez-Remirez, M., Borrero-Palacios, A., Moreno, I., Cebrian, A., Gomez del Pulgar, T., . . . Garcia-Foncillas, J. (2014). DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.

Citación estilo Chicago

Martinez-Useros, Javier, et al. DEK Is a Potential Marker for Aggressive Phenotype and Irinotecan-based Therapy Response in Metastatic Colorectal Cancer. 2014.

Cita MLA

Martinez-Useros, Javier, et al. DEK Is a Potential Marker for Aggressive Phenotype and Irinotecan-based Therapy Response in Metastatic Colorectal Cancer. 2014.